Suppr超能文献

肠道微生物群:FFAR 对胰岛的影响

Gut Microbiota: FFAR Reaching Effects on Islets.

机构信息

Department of Medicine, Division of Endocrinology, Diabetes, and Metabolism, University of Illinois at Chicago, Chicago, Illinois.

Jesse Brown Veterans Affairs Medical Center, Chicago, Illinois.

出版信息

Endocrinology. 2018 Jun 1;159(6):2495-2505. doi: 10.1210/en.2018-00296.

Abstract

The G protein-coupled receptors, free fatty acid (FFA) receptors 2 and 3 (FFA2 and FFA3), belonging to the free fatty acid receptor (FFAR) class, sense a distinct class of nutrients, short chain fatty acids (SCFAs). These receptors participate in both immune and metabolic regulation. The latter includes a role in regulating secretion of metabolic hormones. It was only recently that their role in pancreatic β cells was recognized; these receptors are known now to affect not only insulin secretion but also β-cell survival and proliferation. These observations make them excellent potential therapeutic targets in type 2 diabetes. Moreover, expression on both immune and β cells makes these receptors possible targets in type 1 diabetes. Furthermore, SCFAs are generated by gut microbial fermentative activity; therefore, signaling by FFA2 and FFA3 represents an exciting novel link between the gut microbiota and the β cells. This review enumerates the role of these receptors in β cells revealed so far and discusses possible roles in clinical translation.

摘要

G 蛋白偶联受体,游离脂肪酸(FFA)受体 2 和 3(FFA2 和 FFA3),属于游离脂肪酸受体(FFAR)类,感知一类独特的营养素,即短链脂肪酸(SCFAs)。这些受体参与免疫和代谢调节。后者包括调节代谢激素分泌的作用。直到最近才认识到它们在胰腺β细胞中的作用;现在已知这些受体不仅影响胰岛素分泌,还影响β细胞的存活和增殖。这些观察结果使它们成为 2 型糖尿病的理想潜在治疗靶点。此外,在免疫细胞和β细胞上的表达使这些受体成为 1 型糖尿病的潜在靶点。此外,SCFAs 是由肠道微生物发酵活动产生的;因此,FFA2 和 FFA3 的信号转导代表了肠道微生物群和β细胞之间令人兴奋的新联系。这篇综述列举了迄今为止这些受体在β细胞中所揭示的作用,并讨论了在临床转化中的可能作用。

相似文献

1
Gut Microbiota: FFAR Reaching Effects on Islets.肠道微生物群:FFAR 对胰岛的影响
Endocrinology. 2018 Jun 1;159(6):2495-2505. doi: 10.1210/en.2018-00296.
3
The short-chain fatty acid receptor, FFA2, contributes to gestational glucose homeostasis.短链脂肪酸受体FFA2有助于维持孕期葡萄糖稳态。
Am J Physiol Endocrinol Metab. 2015 Nov 15;309(10):E840-51. doi: 10.1152/ajpendo.00171.2015. Epub 2015 Sep 22.
4
SCFA Receptors in Pancreatic β Cells: Novel Diabetes Targets?胰腺β细胞中的短链脂肪酸受体:新型糖尿病靶点?
Trends Endocrinol Metab. 2016 Sep;27(9):653-664. doi: 10.1016/j.tem.2016.03.011. Epub 2016 Apr 15.
10
Free Fatty Acid Receptors in Health and Disease.游离脂肪酸受体在健康与疾病中的作用
Physiol Rev. 2020 Jan 1;100(1):171-210. doi: 10.1152/physrev.00041.2018. Epub 2019 Sep 5.

引用本文的文献

7
Editorial: Gut physiology-microbes and inflammatory diseases.社论:肠道生理学——微生物与炎症性疾病
Front Physiol. 2023 Jul 21;14:1254228. doi: 10.3389/fphys.2023.1254228. eCollection 2023.
8
Signalling cognition: the gut microbiota and hypothalamic-pituitary-adrenal axis.信号认知:肠道微生物群与下丘脑-垂体-肾上腺轴。
Front Endocrinol (Lausanne). 2023 Jun 19;14:1130689. doi: 10.3389/fendo.2023.1130689. eCollection 2023.

本文引用的文献

1
Free Fatty Acid Receptors in Enteroendocrine Cells.肠内分泌细胞中的游离脂肪酸受体。
Endocrinology. 2018 Jul 1;159(7):2826-2835. doi: 10.1210/en.2018-00261.
7
The intestinal epithelial barrier: a therapeutic target?肠上皮屏障:一个治疗靶点?
Nat Rev Gastroenterol Hepatol. 2017 Jan;14(1):9-21. doi: 10.1038/nrgastro.2016.169. Epub 2016 Nov 16.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验